Position in QURE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,713,022
New position
Shares Held
104,772
first reported quarter
Ownership
0.166%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Propel Bio Management, LLC holds $135,066,196 across 34 Biotechnology names. QURE ranks #24 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMUX |
Immunic, Inc.
|
2,344,779 | $26,027,046 | |
| 2 | ACHV |
Achieve Life Sciences, Inc.
|
3,786,425 | $11,132,089 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
841,272 | $9,346,531 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
147,828 | $5,958,946 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
1,329,899 | $5,957,947 | |
| 6 | VOR |
Vor Biopharma Inc.
|
314,543 | $5,611,447 | |
| 7 | KYTX |
Kyverna Therapeutics, Inc.
|
644,421 | $5,561,353 | |
| 8 | MIST |
Milestone Pharmaceuticals Inc.
|
4,118,321 | $4,900,801 |
All Filings in QURE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,713,022 | 104,772 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||